首页|异钩藤碱调节EGFR/FAK信号通路对肝癌细胞增殖、迁移和5-FU耐药性的影响

异钩藤碱调节EGFR/FAK信号通路对肝癌细胞增殖、迁移和5-FU耐药性的影响

扫码查看
目的 探讨异钩藤碱调节表皮生长因子受体(EGFR)/局部黏着斑激酶(FAK)信号通路对肝癌细胞增殖、迁移和5-氟尿嘧啶(5-FU)耐药性的影响.方法 取对数生长期的HepG2细胞,分为对照组,异钩藤碱低、中、高浓度(32.5、65.0、130.0 μmol·L-1)组,异钩藤碱(130 μmol·L-1)+EGFR激活剂NSC228155(2 μmol L-1)组;对数生长期的5-FU耐药肝癌细胞系 HepG2/5-FU 分为对照组、异钩藤碱(130 μmol·L-1)组、5-FU(60 μmol·L-1)组、异钩藤碱(130 μmol·L-1)+5-FU(60 μmol·L-1)组、异钩藤碱(130 μmol·L-1)+5-FU(60 μmol L-1)+NSC228155(2 μmol L-1)组.给药处理24 h,对照组不给药.EdU染色、CCK-8检测HepG2或HepG2/5-FU细胞增殖;划痕实验检测HepG2或HepG2/5-FU细胞迁移;Western blotting检测细胞中细胞周期蛋白D1(CyclinD1)、迁移侵袭增强子因子1(MIEN1)、P-糖蛋白(P-gp)、p-EGFR、p-FAK蛋白表达.结果 与对照组相比,异钩藤碱低、中、高浓度组EdU阳性率、吸光度(A450)值、划痕愈合率、CyclinD1、MIEN1、p-EGFR、p-FAK蛋白表达显著降低,且呈浓度相关性(P<0.05);与异钩藤碱130.0 μmol·L-1组相比,异钩藤碱+NSC228155组HepG2细胞EdU阳性率、A45.值、划痕愈合率、CyclinD1、MIEN1、p-EGFR、p-FAK蛋白表达显著升高(P<0.05).与对照组相比,5-FU组HepG2/5-FU细胞EdU阳性率、A450值、划痕愈合率、P-gp、p-EGFR、p-FAK蛋白表达显著降低(P<0.05);与异钩藤碱组、5-FU组相比,异钩藤碱+5-FU组HepG2/5-FU细胞EdU阳性率、A45.值、划痕愈合率、P-gp、p-EGFR、p-FAK蛋白表达降低(P<0.05);与异钩藤碱+5-FU组相比,异钩藤碱+5-FU+NSC228155组HepG2/5-FU细胞EdU阳性率、A45.值、划痕愈合率、P-gp、p-EGFR、p-FAK蛋白显著上调(P<0.05).结论 异钩藤碱抑制HepG2细胞增殖、迁移及降低5-FU耐药性的机制可能与阻断EGFR/FAK通路有关.
Effects of isorhynchophylline on proliferation,migration,and 5-FU resistance of liver cancer cells by regulating EGFR/FAK signaling pathway
Objective To investigate the effects of isorhynchophylline(isorhy)on the proliferation,migration,and 5-FU resistance of liver cancer cells by regulating the epidermal growth factor receptor(EGFR)/focal adhesion kinase(FAK)signaling pathway.Methods Logarithmic phase HepG2 cells were divided into control group,low,medium,and high concentration groups of isorhy(32.5,65.0,130.0 μmol·L-1),and the high concentration group of isorhy(130 μmol·L-1)+EGFR activator NSC228155(2 μmol·L-1).Logarithmic phase 5-FU-resistant hepatocellular carcinoma cell line HepG2/5-FU was divided into control group,isorhy(130 μmol·L-1)group,5-FU(60 μmol·L-1)group,isorhy(130 μmol·L-1)+5-FU(60 μmol·L-1)group,and isorhy(130 μmol·L-1)+5-FU(60 μmol·L-1)+NSC228155(2 μmol·L-1)group.The cells were treated with drugs for 24 hours,and the control group was not treated.EdU staining and CCK-8 were applied to detect HepG2 or HepG2/5-FU cell proliferation.Scratch experiment was applied to detect the migration of HepG2 or HepG2/5-FU cells.Western blotting was applied to detect cyclinD1,MIEN1,P-glycoprotein(P-gp),p-EGFR,and p-FAK proteins in cells.Results Compared with the control group,the EdU positive rate,A450 value,scratch healing rate,CyclinD1,MIEN1,p-EGFR,and p-FAK protein expression of HepG2 cells in isorhy group were reduced,in a concentration-dependent manner(P<0.05).Compared with isorhy(130 μmol·L-1)group,the EdU positive rate,A450 value,scratch healing rate,CyclinD1,MIEN1,p-EGFR,and p-FAK protein expression of HepG2 cells in isorhy(130.0 μmol·L-1)+NSC228155 group were increased(P<0.05).Compared with control group,the EdU positive rate,scratch healing rate,A450 value,P-gp,p-EGFR,and p-FAK protein expression of HepG2/5-FU cells in the 5-FU group were reduced(P<0.05).Compared with the isorhy group or 5-FU group,the EdU positive rate,A450 value,scratch healing rate,P-gp,p-EGFR,and p-FAK protein expression of HepG2/5-FU cells in the isorhy+5-FU group were reduced(P<0.05).Compared with the isorhy+5-FU group,the positive rate of EdU,A450 value,scratch healing rate,P-gp,p-EGFR,and p-FAK protein expression in HepG2/5-FU cells in the isorhy+5-FU+NSC228155 group were increased(P<0.05).Conclusion Isorhy may inhibit proliferation,migration,and reduce 5-FU resistance of HepG2 cells by blocking the EGFR/FAK pathway.

isorhynchophyllineliver cancerepidermal growth factor receptor/focal adhesion kinase(EGFR/FAK)pathwayproliferationmigration5-FU resistanceP-glycoprotein(P-gp)

李海燕、栗昭生、赵龙、金春花、张鼐鹏

展开 >

牡丹江医学院附属红旗医院药学部,黑龙江牡丹江 157000

牡丹江医学院第一临床医学院,黑龙江牡丹江 157011

牡丹江医学院附属红旗医院神经内科,黑龙江牡丹江 157000

牡丹江医学院附属红旗医院普外二科,黑龙江牡丹江 157000

展开 >

异钩藤碱 肝癌 表皮生长因子受体/局部黏斑激酶(EGFR/FAK)通路 增殖 迁移 5-FU耐药性 P-糖蛋白(P-gp)

黑龙江省省属高等学校基本科研业务费科研项目

2023-KYYWF-0959

2024

药物评价研究
天津药物研究院 中国药学会

药物评价研究

CSTPCD北大核心
影响因子:1.199
ISSN:1674-6376
年,卷(期):2024.47(6)